We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors May Need to Redo Studies Affected by Disputed Cetero Data
Sponsors May Need to Redo Studies Affected by Disputed Cetero Data
May 9, 2012
Some drug-trial sponsors who used the discredited CRO Cetero Research will need to reanalyze or repeat studies, while others will need to conduct an independent third-party data audit, the FDA told drugmakers in late April.